Vista Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.12M Sell
3,563
-5
-0.1% -$5.9K 1.07% 36
2026
Q2
$4.28M Sell
3,568
-51
-1% -$52.1K 1.08% 37
2026
Q1
$3.33M Sell
3,619
-1,157
-24% -$1.17M 0.88% 44
2025
Q4
$5.13M Sell
4,776
-10
-0.2% -$9.56K 1.34% 23
2025
Q3
$3.65M Buy
4,786
+121
+3% +$90K 1.02% 38
2025
Q2
$3.64M Buy
4,665
+34
+0.7% +$26.4K 1.05% 39
2025
Q1
$3.82M Sell
4,631
-117
-2% -$97.4K 1.17% 34
2024
Q4
$3.67M Sell
4,748
-157
-3% -$130K 1.14% 36
2024
Q3
$4.35M Sell
4,905
-1
-0% -$899 1.39% 24
2024
Q2
$4.44M Buy
4,906
+27
+0.6% +$21.6K 1.48% 18
2024
Q1
$3.8M Buy
4,879
+35
+0.7% +$24.9K 1.29% 28
2023
Q4
$2.82M Buy
+4,844
New +$2.83M 1.03% 39

Other funds holding LLY

Vista Investment Partners's LLY Position: Q3 2026 in Review

Vista Investment Partners reduced its Eli Lilly (LLY) stake by 0.14% in Q3 2026, selling an estimated $5.9K and leaving 3,563 shares worth $4.12M. The position accounts for 1.07% of the portfolio, ranked #36.

Vista Investment Partners first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $5.13M in Q4 2025. 428 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Vista Investment Partners held 3,563 shares of Eli Lilly worth $4.12M as of Q3 2026.
  • Vista Investment Partners sold 5 Eli Lilly shares in Q3 2026, an estimated $5.9K.
  • Eli Lilly made up 1.07% of Vista Investment Partners's portfolio in Q3 2026, its #36 holding.
  • Vista Investment Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
  • Vista Investment Partners's Eli Lilly position peaked at $5.13M in Q4 2025.
  • 428 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Vista Investment Partners's 13F filing for Q3 2026, filed 8 Oct 2026.